Skip to content

Take home naloxone intervention in multicentre emergency settings

Take home naloxone Intervention Multicentre Emergency setting feasibility trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13232859
Enrollment
200
Registered
2018-02-16
Start date
2019-02-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid overdose Injury, Occupational Diseases, Poisoning Other opioids

Interventions

This is a feasibility study for an RCT of Take Home Naloxone (THN) in emergency settings clustered by emergency department (ED) catchment area and local ambulance service. Anonymised linked data outco
this reduced the randomisation options to four, as listed below: Option A: Intervention: Wrexham, Sheffield Control: Bristol, Hull Option B: Intervention: Bristol, Hull Control: Wrexham, Sheffield
a protocol for the supply of THN kits to those eligible for the intervention
a single use THN kit (ampoule of Nalo

Sponsors

Swansea University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Eligible for intervention: Adult (18 years of age or over, male or female) opioid users at risk of overdose who are attended by emergency ambulance paramedic or who attend ED Accompanying friends, relatives or carers (18 years of age or over, male or female) of opioid users at risk of overdose who are attended by emergency ambulance paramedic or who attend ED Eligible for inclusion in outcome follow up and analyses: High risk peers (18 years of age or over, male or female) - opioid users at high risk of fatal opioid overdose who make up a wider peer group who may or may not make contact with emergency services at study site during the study period

Exclusion criteria

Exclusion criteria: 1. Under 18 years of age 2. Actively dissent from involvement in study 3. Non-opioid overdose

Design outcomes

Primary

MeasureTime frame
Mortality (total and opioid overdose related), collected using anonymised data linkage at a single time point 12 months post intervention

Secondary

MeasureTime frame
Collected using anonymised data linkage at a single time point 12 months post intervention: 1. Emergency admissions 2. ITU admissions 3. ED attendances (total and opioid overdose related) 4. 999 attendances (total and opioid overdose related) 5. THN kits issued 6. NHS resource usage

Countries

England, United Kingdom, Wales

Contacts

Public ContactJenna Jones
j.k.jones@swansea.ac.uk+44 (0)1792513424

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026